Science & Technology

Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer

Department of Health and Human Services — National Institutes of Health

Opportunity #: 2R42CA268623-02

Award Ceiling

$999K

Award Floor

$999K

Close Date

Nov 30, 2026

260 days left

Total Funding

$999K

Expected Awards

Posted Date

Sep 24, 2025

Cost Sharing Required

Grants.gov ID

sbir-2R42CA268623-02

Description

STTR Phase Phase II award: "Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer" awarded to NANOCAN THERAPEUTICS CORPORATION in Princeton, New Jersey. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $998,781. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses, Socially/economically disadvantaged

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.